High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck Academic Article uri icon

Overview

MeSH Major

  • Brachytherapy
  • Prostatic Neoplasms
  • Urinary Bladder

abstract

  • Despite the poor prognostic features noted in this cohort of patients with HN malignancies, HFRT was associated with high response rates, good local control, and acceptable toxicity. Sites that were treated with 6Gray per fraction or higher and had not been previously irradiated had the best disease control. A prospective trial is warranted to further refine the use and indications of HFRT in this setting.

publication date

  • September 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5524568

Digital Object Identifier (DOI)

  • 10.1016/j.oraloncology.2016.06.016

PubMed ID

  • 27531876

Additional Document Info

start page

  • 74

end page

  • 80

volume

  • 60